Roche’s Polivy Set For Blockbuster Sales After Frontline Lymphoma Success

First Progress In Frontline DLBCL In 20 Years

 
• By Andrew McConaghie
  
Roche_Basel
While CAR-Ts grabbed the headlines when launched several years ago, Roche's Polivy looks set to have a greater impact on DLBCL treatment.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip